Home Cart 0 Sign in  
X

[ CAS No. 443-26-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 443-26-5
Chemical Structure| 443-26-5
Chemical Structure| 443-26-5
Structure of 443-26-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 443-26-5 ]

Related Doc. of [ 443-26-5 ]

Alternatived Products of [ 443-26-5 ]

Product Details of [ 443-26-5 ]

CAS No. :443-26-5 MDL No. :MFCD00039214
Formula : C9H9FO2 Boiling Point : -
Linear Structure Formula :- InChI Key :RUWPGPOBTHOLHF-UHFFFAOYSA-N
M.W : 168.17 Pubchem ID :67953
Synonyms :

Calculated chemistry of [ 443-26-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.49
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.17
Log Po/w (XLOGP3) : 2.19
Log Po/w (WLOGP) : 2.42
Log Po/w (MLOGP) : 2.67
Log Po/w (SILICOS-IT) : 2.45
Consensus Log Po/w : 2.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.43
Solubility : 0.619 mg/ml ; 0.00368 mol/l
Class : Soluble
Log S (Ali) : -2.38
Solubility : 0.707 mg/ml ; 0.00421 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.15
Solubility : 0.119 mg/ml ; 0.000706 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 443-26-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 443-26-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 443-26-5 ]
  • Downstream synthetic route of [ 443-26-5 ]

[ 443-26-5 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 443-26-5 ]
  • [ 446-24-2 ]
YieldReaction ConditionsOperation in experiment
94% With hydrazine hydrate In ethanol; waterReflux General procedure: Hydrazides (30–58) were synthesized by one pot conventionalmethod24 Benzoic acid or its derivative (10 mmol) was dissolvedin ethanol (20 mL). Sulfuric acid (3 N, 2 mL) was added and thereaction contents were refluxed for six hours. The reaction wasmonitored with TLC. After the completion of the reaction, the reactionmixture was neutralized by adding solid NaHCO3, and filteredto remove excess of NaHCO3. In the neutralized reaction mixture which contains ethyl ester, hydrazine monohydrate (1.5 mL,3 mmol) was added and refluxed for 3–6 h to complete the reaction.Ethanol and unreacted hydrazine were removed by distillationupto 1/3 volume. The reaction contents were cooled, filteredand recrystallized from methanol to obtain the desired hydrazidecrystals (see Supporting information).
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 6014 - 6024
[2] Journal of the American Chemical Society, 1950, vol. 72, p. 1806
[3] Journal of Agricultural and Food Chemistry, 2003, vol. 51, # 1, p. 152 - 155
[4] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 8, p. 2278 - 2282
[5] Journal of Medicinal Chemistry, 2010, vol. 53, # 20, p. 7392 - 7404
[6] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 7836 - 7841
[7] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 18, p. 9892 - 9900
[8] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2286 - 2297
[9] Journal of Heterocyclic Chemistry, 2013, vol. 50, # 4, p. 945 - 948
[10] Tetrahedron, 2014, vol. 70, # 12, p. 2190 - 2194
[11] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[12] Transition Metal Chemistry, 2015, vol. 40, # 6, p. 665 - 671
[13] Medicinal Chemistry, 2015, vol. 11, # 8, p. 798 - 806
[14] Chinese Chemical Letters, 2016, vol. 27, # 1, p. 163 - 167
[15] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 8, p. 1879 - 1888
[16] European Journal of Medicinal Chemistry, 2016, vol. 120, p. 134 - 147
[17] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 11, p. 1998 - 2010
[18] Chemical Biology and Drug Design, 2017, vol. 90, # 2, p. 236 - 243
[19] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 24, p. 5457 - 5462
[20] RSC Advances, 2018, vol. 8, # 12, p. 6306 - 6314
[21] Journal of the Chemical Society of Pakistan, 2018, vol. 40, # 2,
  • 2
  • [ 348-52-7 ]
  • [ 1906-57-6 ]
  • [ 443-26-5 ]
YieldReaction ConditionsOperation in experiment
44% With palladium diacetate In 1-methyl-pyrrolidin-2-one at 20 - 140℃; for 24 h; Inert atmosphere General procedure: An oven-dried Schlenk-tube (10 mL) was charged with Pd source (1 mol percent), and ethyl potassium oxalate (0.75 mmol). The tube was evacuated and backfilled with argon (this procedure was repeated three times). After that, iodobenzene (0.5 mmol) and NMP (1.0 mL) were added by syringe under a counter flow of argon at room temperature. The reaction vessel was closed and then placed under stirring in a preheated oil bath. The reaction mixture was stirred for 24 h. Upon completion of the reaction, the mixture was cooled to room temperature and diluted with ethyl acetate, and analyzed by gas chromatography.
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 43, p. 5796 - 5799
  • 3
  • [ 64-17-5 ]
  • [ 445-29-4 ]
  • [ 443-26-5 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 23, p. 7745 - 7748
[2] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 7836 - 7841
[3] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 18, p. 9892 - 9900
[4] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2286 - 2297
[5] Journal of Heterocyclic Chemistry, 2013, vol. 50, # 4, p. 945 - 948
[6] Transition Metal Chemistry, 2015, vol. 40, # 6, p. 665 - 671
[7] Tetrahedron, 2014, vol. 70, # 12, p. 2190 - 2194
[8] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[9] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 6014 - 6024
[10] Chinese Chemical Letters, 2016, vol. 27, # 1, p. 163 - 167
[11] European Journal of Medicinal Chemistry, 2016, vol. 120, p. 134 - 147
[12] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 11, p. 1998 - 2010
[13] Chemical Biology and Drug Design, 2017, vol. 90, # 2, p. 236 - 243
[14] RSC Advances, 2018, vol. 8, # 12, p. 6306 - 6314
  • 4
  • [ 1829-28-3 ]
  • [ 93-89-0 ]
  • [ 443-26-5 ]
Reference: [1] Chemistry - An Asian Journal, 2013, vol. 8, # 4, p. 705 - 708
  • 5
  • [ 1993-03-9 ]
  • [ 1609-47-8 ]
  • [ 443-26-5 ]
Reference: [1] Advanced Synthesis and Catalysis, 2015, vol. 357, # 14-15, p. 3104 - 3108
  • 6
  • [ 393-52-2 ]
  • [ 443-26-5 ]
Reference: [1] Patent: US4801717, 1989, A,
  • 7
  • [ 64-17-5 ]
  • [ 1041479-61-1 ]
  • [ 201230-82-2 ]
  • [ 443-26-5 ]
Reference: [1] Journal of the American Chemical Society, 2008, vol. 130, # 29, p. 9429 - 9433
  • 8
  • [ 124-38-9 ]
  • [ 348-52-7 ]
  • [ 75-03-6 ]
  • [ 443-26-5 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 11, p. 4314 - 4317
  • 9
  • [ 64-17-5 ]
  • [ 393-52-2 ]
  • [ 443-26-5 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 22, p. 7557 - 7576
[2] Journal of Organic Chemistry, 2008, vol. 73, # 24, p. 9781 - 9783
  • 10
  • [ 367-12-4 ]
  • [ 443-26-5 ]
Reference: [1] Chemistry - An Asian Journal, 2017, vol. 12, # 17, p. 2323 - 2331
  • 11
  • [ 64-17-5 ]
  • [ 201230-82-2 ]
  • [ 16475-34-6 ]
  • [ 443-26-5 ]
Reference: [1] Chemistry - An Asian Journal, 2017, vol. 12, # 17, p. 2323 - 2331
  • 12
  • [ 591-87-7 ]
  • [ 443-26-5 ]
  • [ 445-29-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2018, vol. 57, # 44, p. 14580 - 14584[2] Angew. Chem., 2018, vol. 130, p. 14788 - 14792,5
  • 13
  • [ 64-17-5 ]
  • [ 488-98-2 ]
  • [ 443-26-5 ]
Reference: [1] Dalton Transactions, 2016, vol. 45, # 25, p. 10173 - 10180
  • 14
  • [ 443-26-5 ]
  • [ 445-28-3 ]
Reference: [1] Zeitschrift fuer Physikalische Chemie (Leipzig), 1930, vol. <B> 10, p. 106,119
  • 15
  • [ 288-32-4 ]
  • [ 443-26-5 ]
  • [ 117296-92-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1992, vol. 27, # 3, p. 219 - 228
  • 16
  • [ 443-26-5 ]
  • [ 1214362-62-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 16, p. 4440 - 4444[2] Angew. Chem., 2013, vol. 125, # 16, p. 4536 - 4540,5
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 443-26-5 ]

Fluorinated Building Blocks

Chemical Structure| 394-35-4

[ 394-35-4 ]

Methyl 2-fluorobenzoate

Similarity: 0.96

Chemical Structure| 2967-93-3

[ 2967-93-3 ]

Methyl 2-fluoro-5-methylbenzoate

Similarity: 0.96

Chemical Structure| 362601-90-9

[ 362601-90-9 ]

Methyl 2,5-difluorobenzoate

Similarity: 0.94

Chemical Structure| 451-46-7

[ 451-46-7 ]

Ethyl 4-fluorobenzoate

Similarity: 0.94

Chemical Structure| 74733-25-8

[ 74733-25-8 ]

Methyl 3-fluoro-4-formylbenzoate

Similarity: 0.94

Aryls

Chemical Structure| 394-35-4

[ 394-35-4 ]

Methyl 2-fluorobenzoate

Similarity: 0.96

Chemical Structure| 2967-93-3

[ 2967-93-3 ]

Methyl 2-fluoro-5-methylbenzoate

Similarity: 0.96

Chemical Structure| 362601-90-9

[ 362601-90-9 ]

Methyl 2,5-difluorobenzoate

Similarity: 0.94

Chemical Structure| 451-46-7

[ 451-46-7 ]

Ethyl 4-fluorobenzoate

Similarity: 0.94

Chemical Structure| 74733-25-8

[ 74733-25-8 ]

Methyl 3-fluoro-4-formylbenzoate

Similarity: 0.94

Esters

Chemical Structure| 394-35-4

[ 394-35-4 ]

Methyl 2-fluorobenzoate

Similarity: 0.96

Chemical Structure| 2967-93-3

[ 2967-93-3 ]

Methyl 2-fluoro-5-methylbenzoate

Similarity: 0.96

Chemical Structure| 362601-90-9

[ 362601-90-9 ]

Methyl 2,5-difluorobenzoate

Similarity: 0.94

Chemical Structure| 451-46-7

[ 451-46-7 ]

Ethyl 4-fluorobenzoate

Similarity: 0.94

Chemical Structure| 74733-25-8

[ 74733-25-8 ]

Methyl 3-fluoro-4-formylbenzoate

Similarity: 0.94